Cue Biopharma Inc

Biotech Stocks Healthcare Stocks

$31.56

+1.13 (+3.71%)

As of Jun 30, 10:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target -50.1% upside

Low Target $10.91

Average Target $15.75

High Target $18.65

Current Price $31.56

Current
$31.56

Target
$15.75

$10.91 $15.75 avg $18.65

Scenario Analysis

Bear Case

$10.91

-65.4%

Low target

Base Case

$15.75

-50.1%

Avg target

Bull Case

$18.65

+-40.9%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$41.42

-23.8% from high

52-Week Low

$4.97

+535.0% from low

Target vs 52W High

$15.75

-62.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%